azauridine has been researched along with Coma in 1 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dantzig, PI | 1 |
| McEvoy, B | 1 |
| Mauro, J | 1 |
| Rayhanzadeh, S | 1 |
1 trial available for azauridine and Coma
| Article | Year |
|---|---|
Low dose azaribine in the treatment of psoriasis.
Topics: Adult; Aged; Anemia; Aphasia; Arthritis; Azauridine; Clinical Trials as Topic; Coma; Headache; Human | 1974 |